 Samuel Gubbels
Concepts (363)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implants | 8 | 2023 | 91 | 3.280 |
Why?
| | Neuroma, Acoustic | 9 | 2024 | 51 | 3.130 |
Why?
| | Cochlear Implantation | 8 | 2023 | 76 | 2.820 |
Why?
| | Cochlea | 10 | 2024 | 72 | 2.710 |
Why?
| | Hearing Loss | 8 | 2025 | 221 | 2.270 |
Why?
| | Speech Perception | 6 | 2024 | 82 | 2.110 |
Why?
| | Hearing | 9 | 2025 | 118 | 1.750 |
Why?
| | Audiometry, Pure-Tone | 5 | 2024 | 30 | 1.490 |
Why?
| | Semicircular Canals | 4 | 2021 | 23 | 1.420 |
Why?
| | Ear, Inner | 6 | 2024 | 49 | 1.210 |
Why?
| | Nestin | 3 | 2024 | 19 | 1.200 |
Why?
| | Otitis Media | 7 | 2022 | 165 | 1.060 |
Why?
| | Radiosurgery | 3 | 2019 | 344 | 1.040 |
Why?
| | Deafness | 5 | 2023 | 77 | 1.040 |
Why?
| | Otitis Media with Effusion | 3 | 2014 | 20 | 0.910 |
Why?
| | Vestibule, Labyrinth | 2 | 2024 | 65 | 0.900 |
Why?
| | Hair Cells, Auditory | 5 | 2024 | 39 | 0.870 |
Why?
| | Nasopharyngeal Diseases | 2 | 2014 | 5 | 0.850 |
Why?
| | Unnecessary Procedures | 2 | 2014 | 50 | 0.800 |
Why?
| | Gentamicins | 1 | 2023 | 54 | 0.800 |
Why?
| | Labyrinth Diseases | 3 | 2020 | 7 | 0.740 |
Why?
| | Endoscopy | 3 | 2020 | 318 | 0.720 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 25 | 0.710 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2021 | 14 | 0.700 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 80 | 0.670 |
Why?
| | Otolaryngologists | 1 | 2020 | 13 | 0.670 |
Why?
| | Ear Neoplasms | 2 | 2024 | 9 | 0.650 |
Why?
| | Temporal Bone | 6 | 2024 | 45 | 0.630 |
Why?
| | Paraganglioma | 1 | 2020 | 52 | 0.620 |
Why?
| | Skull Base Neoplasms | 1 | 2019 | 30 | 0.620 |
Why?
| | Tinnitus | 3 | 2018 | 57 | 0.610 |
Why?
| | Vertigo | 3 | 2023 | 39 | 0.590 |
Why?
| | Eustachian Tube | 1 | 2018 | 8 | 0.590 |
Why?
| | Hearing Loss, Sensorineural | 6 | 2022 | 67 | 0.580 |
Why?
| | Meningioma | 1 | 2019 | 91 | 0.580 |
Why?
| | Meningeal Neoplasms | 1 | 2019 | 100 | 0.570 |
Why?
| | Magnetic Resonance Imaging | 6 | 2023 | 3566 | 0.560 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2018 | 81 | 0.560 |
Why?
| | Hearing Aids | 2 | 2016 | 77 | 0.540 |
Why?
| | Radiation Injuries | 1 | 2018 | 145 | 0.540 |
Why?
| | Physicians' Offices | 1 | 2016 | 16 | 0.520 |
Why?
| | Surgical Flaps | 2 | 2016 | 130 | 0.510 |
Why?
| | Humans | 63 | 2025 | 137585 | 0.500 |
Why?
| | Membrane Proteins | 2 | 2020 | 1164 | 0.490 |
Why?
| | Hearing Tests | 3 | 2025 | 47 | 0.490 |
Why?
| | Suture Anchors | 1 | 2016 | 33 | 0.490 |
Why?
| | Sex Characteristics | 1 | 2021 | 762 | 0.480 |
Why?
| | Skin Transplantation | 1 | 2016 | 85 | 0.480 |
Why?
| | Device Removal | 1 | 2016 | 136 | 0.450 |
Why?
| | Benign Paroxysmal Positional Vertigo | 3 | 2021 | 4 | 0.450 |
Why?
| | Head and Neck Neoplasms | 1 | 2020 | 606 | 0.450 |
Why?
| | Cranial Fossa, Middle | 2 | 2020 | 15 | 0.450 |
Why?
| | Bacteriological Techniques | 1 | 2014 | 73 | 0.440 |
Why?
| | Cell Differentiation | 2 | 2021 | 1991 | 0.440 |
Why?
| | Blood | 1 | 2014 | 107 | 0.440 |
Why?
| | Hyperacusis | 1 | 2014 | 8 | 0.440 |
Why?
| | Cholesteatoma | 1 | 2014 | 10 | 0.430 |
Why?
| | Tomography, X-Ray Computed | 7 | 2016 | 2691 | 0.420 |
Why?
| | Jugular Veins | 1 | 2013 | 41 | 0.400 |
Why?
| | Glomus Jugulare Tumor | 1 | 2012 | 5 | 0.400 |
Why?
| | Polyvinyls | 1 | 2012 | 21 | 0.390 |
Why?
| | Carotid Body Tumor | 1 | 2012 | 5 | 0.390 |
Why?
| | Otologic Surgical Procedures | 5 | 2024 | 14 | 0.390 |
Why?
| | Patient Selection | 1 | 2016 | 696 | 0.390 |
Why?
| | Influenza B virus | 1 | 2012 | 44 | 0.390 |
Why?
| | Carotid Artery, Internal | 1 | 2012 | 42 | 0.390 |
Why?
| | Cranial Nerve Diseases | 1 | 2012 | 42 | 0.380 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 752 | 0.380 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2012 | 19 | 0.380 |
Why?
| | Bacteremia | 1 | 2014 | 214 | 0.380 |
Why?
| | Mutation | 2 | 2020 | 3958 | 0.370 |
Why?
| | Stapes Surgery | 2 | 2023 | 10 | 0.370 |
Why?
| | Denmark | 5 | 2016 | 46 | 0.360 |
Why?
| | Influenza A virus | 1 | 2012 | 107 | 0.360 |
Why?
| | Middle Aged | 20 | 2024 | 33479 | 0.360 |
Why?
| | Melanoma | 1 | 2018 | 760 | 0.360 |
Why?
| | Retrospective Studies | 15 | 2024 | 15657 | 0.350 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 596 | 0.350 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 148 | 0.350 |
Why?
| | Artifacts | 2 | 2023 | 129 | 0.340 |
Why?
| | Female | 26 | 2024 | 73304 | 0.330 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.330 |
Why?
| | Aging | 2 | 2021 | 1864 | 0.330 |
Why?
| | Embolization, Therapeutic | 1 | 2012 | 229 | 0.330 |
Why?
| | Male | 29 | 2024 | 67762 | 0.330 |
Why?
| | Adult | 22 | 2025 | 37929 | 0.320 |
Why?
| | Laser Therapy | 2 | 2023 | 130 | 0.320 |
Why?
| | Genetic Therapy | 5 | 2020 | 297 | 0.310 |
Why?
| | Transfection | 2 | 2009 | 945 | 0.310 |
Why?
| | Animals | 17 | 2024 | 36940 | 0.290 |
Why?
| | Mice | 11 | 2024 | 17787 | 0.290 |
Why?
| | Cerebrospinal Fluid Otorrhea | 1 | 2007 | 5 | 0.290 |
Why?
| | Encephalocele | 1 | 2007 | 10 | 0.280 |
Why?
| | Bacteria | 1 | 2014 | 858 | 0.280 |
Why?
| | Nasopharynx | 2 | 2022 | 76 | 0.280 |
Why?
| | Uterus | 1 | 2008 | 215 | 0.270 |
Why?
| | Urinary Tract Infections | 2 | 2022 | 188 | 0.260 |
Why?
| | Aged | 14 | 2024 | 23961 | 0.260 |
Why?
| | Intensive Care Units | 1 | 2012 | 827 | 0.260 |
Why?
| | Cross Infection | 2 | 2022 | 256 | 0.260 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 243 | 0.260 |
Why?
| | Tracheal Diseases | 1 | 2006 | 15 | 0.250 |
Why?
| | Bioprosthesis | 1 | 2006 | 40 | 0.250 |
Why?
| | Influenza, Human | 1 | 2012 | 622 | 0.250 |
Why?
| | Neurons | 1 | 2015 | 1590 | 0.250 |
Why?
| | Petrous Bone | 1 | 2024 | 7 | 0.230 |
Why?
| | Cholesteatoma, Middle Ear | 1 | 2024 | 3 | 0.230 |
Why?
| | Treatment Outcome | 10 | 2024 | 10811 | 0.230 |
Why?
| | Trachea | 1 | 2006 | 237 | 0.220 |
Why?
| | Airway Obstruction | 1 | 2006 | 162 | 0.220 |
Why?
| | Saccule and Utricle | 1 | 2024 | 6 | 0.220 |
Why?
| | Incidence | 5 | 2016 | 2804 | 0.210 |
Why?
| | Audiometry | 2 | 2014 | 29 | 0.210 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2003 | 16 | 0.210 |
Why?
| | Cadaver | 5 | 2023 | 296 | 0.210 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2003 | 44 | 0.200 |
Why?
| | Penicillins | 1 | 2023 | 58 | 0.200 |
Why?
| | Meniere Disease | 1 | 2023 | 32 | 0.200 |
Why?
| | Neurofibromatosis 2 | 1 | 2022 | 5 | 0.190 |
Why?
| | Synapses | 2 | 2021 | 427 | 0.190 |
Why?
| | Migraine Disorders | 1 | 2023 | 102 | 0.180 |
Why?
| | Haemophilus Infections | 1 | 2022 | 42 | 0.180 |
Why?
| | Otolithic Membrane | 1 | 2021 | 4 | 0.180 |
Why?
| | Microsurgery | 2 | 2020 | 75 | 0.180 |
Why?
| | Labyrinthitis | 1 | 2021 | 2 | 0.180 |
Why?
| | Stem Cell Transplantation | 2 | 2021 | 176 | 0.180 |
Why?
| | Neurons, Efferent | 1 | 2021 | 8 | 0.180 |
Why?
| | Aged, 80 and over | 6 | 2016 | 7635 | 0.180 |
Why?
| | Vestibular Nerve | 1 | 2021 | 18 | 0.170 |
Why?
| | Vestibular Diseases | 1 | 2021 | 25 | 0.170 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 623 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 30 | 0.170 |
Why?
| | Mice, Transgenic | 2 | 2016 | 2167 | 0.170 |
Why?
| | Noise | 1 | 2021 | 65 | 0.170 |
Why?
| | Scoliosis | 1 | 2023 | 215 | 0.170 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 611 | 0.160 |
Why?
| | Ear, Middle | 4 | 2022 | 85 | 0.160 |
Why?
| | Hypersensitivity | 1 | 2023 | 257 | 0.160 |
Why?
| | Magnets | 1 | 2019 | 19 | 0.160 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.150 |
Why?
| | Microbiota | 3 | 2022 | 762 | 0.150 |
Why?
| | Hearing Loss, Sudden | 1 | 2018 | 6 | 0.150 |
Why?
| | Hearing Loss, Bilateral | 1 | 2018 | 12 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 341 | 0.150 |
Why?
| | Mucous Membrane | 1 | 2018 | 125 | 0.140 |
Why?
| | Surgical Equipment | 1 | 2017 | 11 | 0.140 |
Why?
| | Neurotology | 1 | 2017 | 2 | 0.140 |
Why?
| | Hearing Loss, Noise-Induced | 1 | 2017 | 13 | 0.140 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 122 | 0.140 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 390 | 0.130 |
Why?
| | Hospitals | 3 | 2022 | 691 | 0.130 |
Why?
| | Genetic Testing | 1 | 2020 | 460 | 0.130 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5757 | 0.130 |
Why?
| | Dissection | 1 | 2017 | 52 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 657 | 0.130 |
Why?
| | Infant | 7 | 2019 | 9465 | 0.130 |
Why?
| | Regeneration | 1 | 2018 | 197 | 0.130 |
Why?
| | Patient Positioning | 1 | 2017 | 67 | 0.130 |
Why?
| | Hearing Loss, Unilateral | 1 | 2016 | 5 | 0.130 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 179 | 0.120 |
Why?
| | Electrodes, Implanted | 1 | 2016 | 109 | 0.120 |
Why?
| | Diagnosis, Differential | 5 | 2021 | 1483 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 812 | 0.120 |
Why?
| | Organogenesis | 1 | 2016 | 58 | 0.120 |
Why?
| | Automation | 1 | 2016 | 95 | 0.120 |
Why?
| | Age Factors | 3 | 2012 | 3295 | 0.120 |
Why?
| | Scalp | 1 | 2016 | 35 | 0.120 |
Why?
| | Epidemiological Monitoring | 1 | 2016 | 60 | 0.120 |
Why?
| | Adolescent | 8 | 2023 | 21513 | 0.120 |
Why?
| | Child, Preschool | 7 | 2019 | 11074 | 0.120 |
Why?
| | Plant Lectins | 1 | 2015 | 8 | 0.120 |
Why?
| | Ifosfamide | 1 | 2015 | 37 | 0.120 |
Why?
| | Estrogen Antagonists | 1 | 2015 | 45 | 0.120 |
Why?
| | Durapatite | 2 | 2021 | 37 | 0.110 |
Why?
| | Child | 9 | 2023 | 21935 | 0.110 |
Why?
| | Ki-67 Antigen | 1 | 2015 | 112 | 0.110 |
Why?
| | Etoposide | 1 | 2015 | 158 | 0.110 |
Why?
| | Quality of Life | 3 | 2023 | 2892 | 0.110 |
Why?
| | Audiology | 1 | 2014 | 20 | 0.110 |
Why?
| | Educational Measurement | 1 | 2017 | 289 | 0.110 |
Why?
| | Tamoxifen | 1 | 2015 | 202 | 0.110 |
Why?
| | Pedigree | 3 | 2020 | 514 | 0.110 |
Why?
| | Luminescent Proteins | 1 | 2015 | 179 | 0.110 |
Why?
| | Animals, Newborn | 1 | 2016 | 844 | 0.110 |
Why?
| | Methotrexate | 1 | 2015 | 260 | 0.110 |
Why?
| | Vestibular Evoked Myogenic Potentials | 1 | 2013 | 3 | 0.100 |
Why?
| | Head Injuries, Closed | 2 | 2014 | 48 | 0.100 |
Why?
| | Reproducibility of Results | 3 | 2017 | 3284 | 0.100 |
Why?
| | Eye Movement Measurements | 1 | 2013 | 13 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 991 | 0.100 |
Why?
| | Young Adult | 6 | 2019 | 13209 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1809 | 0.100 |
Why?
| | Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2012 | 4 | 0.100 |
Why?
| | Central Nervous System Cysts | 1 | 2012 | 14 | 0.100 |
Why?
| | Oral Surgical Procedures | 2 | 2011 | 8 | 0.100 |
Why?
| | Follow-Up Studies | 5 | 2010 | 5131 | 0.100 |
Why?
| | Salmonella Food Poisoning | 1 | 2012 | 12 | 0.100 |
Why?
| | Meat Products | 1 | 2012 | 25 | 0.100 |
Why?
| | Disease Notification | 1 | 2012 | 17 | 0.100 |
Why?
| | Food Contamination | 1 | 2012 | 49 | 0.090 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 436 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1774 | 0.090 |
Why?
| | Seasons | 1 | 2014 | 547 | 0.090 |
Why?
| | Laryngoscopy | 1 | 2013 | 109 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 692 | 0.090 |
Why?
| | Phenotype | 1 | 2020 | 3196 | 0.090 |
Why?
| | Disease Progression | 1 | 2019 | 2757 | 0.090 |
Why?
| | Labyrinth Supporting Cells | 1 | 2011 | 3 | 0.090 |
Why?
| | Organ of Corti | 1 | 2011 | 14 | 0.090 |
Why?
| | Radiography | 1 | 2014 | 822 | 0.090 |
Why?
| | Viral Tropism | 1 | 2011 | 31 | 0.090 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2011 | 9 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 2031 | 0.090 |
Why?
| | Age Distribution | 1 | 2012 | 392 | 0.090 |
Why?
| | Sex Distribution | 1 | 2012 | 375 | 0.090 |
Why?
| | Foodborne Diseases | 1 | 2012 | 57 | 0.090 |
Why?
| | Ear Canal | 1 | 2011 | 15 | 0.090 |
Why?
| | Skull Base | 2 | 2021 | 53 | 0.090 |
Why?
| | Ganglion Cysts | 1 | 2011 | 9 | 0.090 |
Why?
| | Ear Diseases | 1 | 2011 | 15 | 0.090 |
Why?
| | Lasers | 2 | 2023 | 130 | 0.090 |
Why?
| | Cranial Nerve Neoplasms | 1 | 2010 | 7 | 0.090 |
Why?
| | Sex Factors | 2 | 2014 | 2071 | 0.090 |
Why?
| | Dependovirus | 1 | 2011 | 68 | 0.090 |
Why?
| | Zygoma | 1 | 2010 | 8 | 0.090 |
Why?
| | Neurosurgical Procedures | 1 | 2012 | 197 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1946 | 0.080 |
Why?
| | Salmonella typhimurium | 1 | 2012 | 183 | 0.080 |
Why?
| | Adenoviridae | 1 | 2011 | 193 | 0.080 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 240 | 0.080 |
Why?
| | Cost of Illness | 1 | 2012 | 308 | 0.080 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 170 | 0.080 |
Why?
| | Genetic Vectors | 1 | 2011 | 319 | 0.080 |
Why?
| | Abscess | 1 | 2010 | 75 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2607 | 0.080 |
Why?
| | Electroencephalography | 1 | 2012 | 423 | 0.080 |
Why?
| | Clinical Competence | 1 | 2017 | 1118 | 0.080 |
Why?
| | Maxilla | 1 | 2009 | 38 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 660 | 0.080 |
Why?
| | Skull Fractures | 1 | 2009 | 36 | 0.080 |
Why?
| | Electroporation | 1 | 2009 | 38 | 0.070 |
Why?
| | Middle Ear Ventilation | 1 | 2008 | 15 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2016 | 2475 | 0.070 |
Why?
| | Comorbidity | 1 | 2014 | 1622 | 0.070 |
Why?
| | Disease Outbreaks | 1 | 2012 | 395 | 0.070 |
Why?
| | Prospective Studies | 3 | 2012 | 7604 | 0.070 |
Why?
| | Electric Conductivity | 1 | 2008 | 86 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 740 | 0.070 |
Why?
| | Dyneins | 1 | 2008 | 33 | 0.070 |
Why?
| | Population Surveillance | 1 | 2012 | 482 | 0.070 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 580 | 0.070 |
Why?
| | Swine | 2 | 2012 | 775 | 0.070 |
Why?
| | Cleft Lip | 1 | 2008 | 52 | 0.070 |
Why?
| | Myosins | 1 | 2008 | 135 | 0.070 |
Why?
| | Cleft Palate | 1 | 2008 | 68 | 0.070 |
Why?
| | Bone Cements | 1 | 2007 | 43 | 0.070 |
Why?
| | Chronic Disease | 1 | 2014 | 1793 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2008 | 4295 | 0.070 |
Why?
| | Craniotomy | 1 | 2007 | 77 | 0.070 |
Why?
| | Mechanotransduction, Cellular | 1 | 2008 | 111 | 0.070 |
Why?
| | Internship and Residency | 1 | 2017 | 1147 | 0.070 |
Why?
| | Tonsillar Neoplasms | 1 | 2005 | 11 | 0.060 |
Why?
| | Neck Dissection | 1 | 2005 | 23 | 0.060 |
Why?
| | Postoperative Care | 1 | 2007 | 261 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1692 | 0.060 |
Why?
| | Random Allocation | 1 | 2006 | 353 | 0.060 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2005 | 94 | 0.060 |
Why?
| | Prevalence | 1 | 2012 | 2734 | 0.060 |
Why?
| | Neck | 1 | 2005 | 101 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 156 | 0.060 |
Why?
| | Biomarkers | 1 | 2016 | 4149 | 0.060 |
Why?
| | Rabbits | 1 | 2006 | 794 | 0.060 |
Why?
| | Neurilemmoma | 1 | 2024 | 24 | 0.060 |
Why?
| | Biopsy | 2 | 2011 | 1129 | 0.060 |
Why?
| | Models, Animal | 1 | 2006 | 384 | 0.060 |
Why?
| | Safety | 1 | 2006 | 338 | 0.050 |
Why?
| | Hearing Disorders | 1 | 2003 | 8 | 0.050 |
Why?
| | Biocompatible Materials | 1 | 2007 | 425 | 0.050 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 36 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2024 | 216 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2014 | 6079 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2012 | 3556 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2021 | 2654 | 0.050 |
Why?
| | Algorithms | 3 | 2017 | 1704 | 0.050 |
Why?
| | Eye Diseases | 1 | 2003 | 87 | 0.050 |
Why?
| | Hospitalization | 1 | 2012 | 2199 | 0.050 |
Why?
| | Hydroxyapatites | 1 | 2021 | 13 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 153 | 0.050 |
Why?
| | Esthetics | 1 | 2021 | 51 | 0.050 |
Why?
| | Diagnostic Techniques, Otological | 1 | 2021 | 2 | 0.050 |
Why?
| | Lithiasis | 1 | 2021 | 3 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 63 | 0.040 |
Why?
| | Recurrence | 1 | 2024 | 1060 | 0.040 |
Why?
| | Facial Nerve | 1 | 2021 | 38 | 0.040 |
Why?
| | Auditory Threshold | 2 | 2011 | 41 | 0.040 |
Why?
| | Scala Tympani | 1 | 2020 | 5 | 0.040 |
Why?
| | Nose | 1 | 2020 | 67 | 0.040 |
Why?
| | Infection Control | 1 | 2022 | 167 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2005 | 683 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2021 | 207 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2003 | 565 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 51 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 549 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 76 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2012 | 5778 | 0.040 |
Why?
| | Finland | 1 | 2019 | 85 | 0.040 |
Why?
| | Pregnancy | 2 | 2009 | 6763 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 242 | 0.040 |
Why?
| | Pharmacokinetics | 1 | 2018 | 29 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 188 | 0.040 |
Why?
| | Incus | 1 | 2017 | 6 | 0.030 |
Why?
| | Ear Ossicles | 1 | 2017 | 11 | 0.030 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 99 | 0.030 |
Why?
| | Exome | 1 | 2018 | 231 | 0.030 |
Why?
| | Stapes | 1 | 2017 | 24 | 0.030 |
Why?
| | Iatrogenic Disease | 1 | 2017 | 67 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 956 | 0.030 |
Why?
| | Pressure | 1 | 2017 | 225 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 452 | 0.030 |
Why?
| | Forecasting | 1 | 2018 | 389 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 431 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 730 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 795 | 0.030 |
Why?
| | Speech Intelligibility | 1 | 2014 | 5 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2018 | 365 | 0.030 |
Why?
| | Time | 1 | 2014 | 83 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 951 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2005 | 2129 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1079 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2847 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2189 | 0.020 |
Why?
| | Bacteriophage Typing | 1 | 2012 | 1 | 0.020 |
Why?
| | Abattoirs | 1 | 2012 | 2 | 0.020 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 24 | 0.020 |
Why?
| | Minisatellite Repeats | 1 | 2012 | 42 | 0.020 |
Why?
| | Cues | 1 | 2014 | 314 | 0.020 |
Why?
| | Microinjections | 1 | 2011 | 86 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2011 | 127 | 0.020 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 50 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2426 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2011 | 312 | 0.020 |
Why?
| | Functional Laterality | 1 | 2010 | 223 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1024 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 402 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2009 | 106 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 363 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1272 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 889 | 0.020 |
Why?
| | Probability | 1 | 2008 | 304 | 0.020 |
Why?
| | Gestational Age | 1 | 2011 | 910 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 594 | 0.020 |
Why?
| | RNA Interference | 1 | 2007 | 469 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 5079 | 0.020 |
Why?
| | Fluorouracil | 1 | 2005 | 208 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2005 | 389 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 352 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2007 | 578 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 860 | 0.010 |
Why?
| | Cisplatin | 1 | 2005 | 320 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1066 | 0.010 |
Why?
| | United States | 1 | 2019 | 14841 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 3457 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 6828 | 0.010 |
Why?
|
|
Gubbels's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|